-
- TRL (Technology readiness level) -
-
- Titre Injectable solution for cells preservation
- Description Solution which preserves the quality / quantity and the functionality of cells during at least 48 hours at 4°C.
Proof of the concept examples:
Ex-vivo expanded CD34+ cord blood cells (most vulnerable cells) were stored at 4°C in two media: 4 % of Human Serum Albumin (HAS 4%) and Injectable solution (SEC).
- Bénéfices Potential solution for cells transportation and storage in view of transplantation, it should be conducted in 48 – 72 hours.
- Nouveauté • Injectable solution of hematopoietic graft to patients, without previous rinsing.
• All components of the solution are approved as injectable by the drug approval administrations (FDA, EMA, ANSM).
• Solution compatible with any kind of injection (intravenous, intramuscular....).
• The viability and the functionality of stem cells compatible with therapeutic uses.
• Can be used for: Fresh cells, previously frozen cells or ex-vivo expanded cells.
- Mots clés Injectable solution, cells conservation and preservation, graft, cord blood cells, peripheral blood cells, bone marrow cells, cells transplantation
- Secteurs Health
